Objectives: To define the prevalence of PHP in patients with RA. Methods: All RA patients who were registered in the local part of Danish Danbio registry were included in this study. Patients'demographic data and serology results (rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (anticcp)) were extracted from Danbio. Patients' electronic hospital records including laboratory results (Parathyroid hormone (PTH) and calcium levels) were reviewed to reveal if they had been diagnosed with PHP as well.
Background: Rheumatoid artritis (RA) is a chronic and autoimmune disorder that primarily affects middle and older ages. Comorbidities are important during RA treatment. Objectives: We aim to determine the frequency of comorbidites and surgical history in the RA patients who receive biological agents. Methods: Hacettepe University Biologic Registry (HUR-BIO) includes demographic and clinical data of patients treated with biological agent since 2005. By August 2016, 1235 RA patients were recorded in the database. Age, gender, smoking habits, disease duration, rheumatoid factor, anti citrullinated peptide (CCP), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), current and previous treatments, comorbidites and surgical history of patients were analyzed. Comorbidites and surgery history were determined by patients medical records. Disease activity was estimated by the 28-joint activity calculator-C reactive protein (DAS28-CRP). Functional assessment was evaluated by the Health Assessment Questionnaire (HAQ). Results: Mean age (SD) of the patients (79,8% women) was 53,1 (12,6) and the mean disease duration was 11,0 (7,7) years. Of patients, 166 (16,6%) were older than 65 years. A total of 630 (63%) patients education level were less than high school, 197 (19,7%) Background: Patients with rheumatoid arthritis (RA) have a higher risk to develop cardiovascular complications than general population (1), leading to a decrease in life expectancy of 3 to 10 years (2). RA is associated to increased left ventricle mass, pericardial effusion and diastolic dysfunction (3). Objectives: The aim of this study was to assess the structure and function of the left ventricle in patients with RA and compare the results with matched controls. Methods: We designed an observational cross-section case-control study. Patients diagnosed with RA according to the 1987 ACR and/or 2010 ACR/EULAR classification criteria, 40-75 years old, with no overlap syndromes, atherosclerotic cardiovascular disease or hypertension were included. Subjects for the control group were matched by sex, age and comorbidities. A board-certified cardiologist performed a transthoracic echocardiogram. Results: We included a total of 44 RA-patients and 26 control subjects. Table  1 summarizes the demographic characteristics for each group. Left ventricular concentric remodeling (LVCR), defined as a relative wall thickness (RWT) >0.42 cm and a left ventricular mass index (LVMI) ≤95 gm/m 2 in women and ≤115 gm/m 2 in men, was found in 14 patients (32.6%) of the RA-group and 2 subjects (8%) of the control group; this difference was statistically significant (p=0.021). When we analyzed general abnormalities of left ventricle (either LVCR or left ventricular concentric hypertrophy [RWT >0.42 cm and LVMI >95 gm/m 2 in women, >115 gm/m 2 in men]) we found 15 RA patients (34.1%) with abnormalities and 3 subjects in the control group (11.5%) (p=0.037). There were no statistically significant differences among the groups in LVMI, diastolic dysfunction, global longitudinal strain or ejection fraction. Conclusions: Left ventricle concentric remodeling is more prevalent in RApatients when compared to controls. Further research is needed to determine the impact of these findings in the clinical prognosis of RA-patients.
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